Cargando…
Defining myocardial fibrosis in haemodialysis patients with non-contrast cardiac magnetic resonance
BACKGROUND: Extent of myocardial fibrosis (MF) determined using late gadolinium enhanced (LGE) predicts outcomes, but gadolinium is contraindicated in advanced renal disease. We assessed the ability of native T1-mapping to identify and quantify MF in aortic stenosis patients (AS) as a model for use...
Autores principales: | Graham-Brown, M. P., Singh, A. S., Gulsin, G. S., Levelt, E., Arnold, J. A., Stensel, D. J., Burton, J. O., McCann, G. P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044074/ https://www.ncbi.nlm.nih.gov/pubmed/30005636 http://dx.doi.org/10.1186/s12872-018-0885-2 |
Ejemplares similares
-
The reliability and feasibility of non-contrast adenosine stress cardiovascular magnetic resonance T1 mapping in patients on haemodialysis
por: Poli, Federica E, et al.
Publicado: (2020) -
The reproducibility of cardiac magnetic resonance imaging measures of aortic stiffness and their relationship to cardiac structure in prevalent haemodialysis patients
por: Graham-Brown, Matthew P M, et al.
Publicado: (2018) -
Imaging of Myocardial Fibrosis in Patients with End-Stage Renal Disease: Current Limitations and Future Possibilities
por: Graham-Brown, M. P. M., et al.
Publicado: (2017) -
Cardiovascular magnetic resonance in the evaluation of heart valve disease
por: Gulsin, G. S., et al.
Publicado: (2017) -
MECHANISMS IN ENDOCRINOLOGY: Diabetic cardiomyopathy: pathophysiology and potential metabolic interventions state of the art review
por: Levelt, Eylem, et al.
Publicado: (2018)